InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Levine Joshua, Chief Executive Officer. Insider active across 3 companies, notably Natus Medical INC. Cumulatively, 8 reports have been published. Split: 2 buys · 2 sells. Total volume traded: €176k. History available since 17 June 2021. The latest transaction was filed on 14 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Levine Joshua
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
10,000 shares@ US$4.75Common StockSEC:0001829126-26-008925:0
Canonical exit: 12 Nov 2026 (T+90)
37,387 shares@ US$33.5083.0% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-22-000098:0
5,075 shares0Common Stock, $0.001 par value per shareSEC:0000878526-22-000047:0
250,501 shares0Common StockSEC:0001214659-21-011053:0
15,741 shares@ US$3.960.17% mcap20.0% of flowCommon StockSEC:0001214659-21-010427:0
15,741 shares@ US$3.9666.7% of flowCommon StockSEC:0001214659-21-010202:0
8,680 shares@ US$3.6333.3% of flowCommon StockSEC:0001214659-21-008821:0
Canonical exit: 16 Nov 2021 (T+90)
5,214 shares@ US$28.779.3% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-21-000067:0
8 of 8 declarations
About Levine Joshua
Joshua Levine is the CEO and Director of NATUS MEDICAL INC and ACCURAY INC. As a leader, he is responsible for the strategic and operational direction of these companies. His expertise in the medical sector and ability to lead teams enable him to drive innovation and growth. He plays a key role in business development and stakeholder engagement.
